Zobrazeno 1 - 10
of 42
pro vyhledávání: ''
Publikováno v:
Cells, Vol 10, Iss 1820, p 1820 (2021)
Cells
Volume 10
Issue 7
Cells
Volume 10
Issue 7
Background: Osteopontin (OPN) splice variants are identified as predictors of tumour progression and therapeutic resistance in certain types of solid tumours. However, their roles in gastric cancer (GC) remain poorly characterized. The current study
Autor:
Francisco Ruiz-Cabello, Francisco Perea, Hernani Gil-Julio, Natalia Aptsiauri, Jose Manuel Cozar, Antonio Rodriguez-Nicolas, Amanda Rocío González-Ramírez, Ángel Concha, Federico Garrido
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7248, p 7248 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 14
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
International Journal of Molecular Sciences
Volume 22
Issue 14
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Cancer eradication and clinical outcome of immunotherapy depend on tumor cell immunogenicity, including HLA class I (HLA-I) and PD-L1 expression on malignant cells, and on the characteristics of the tumor microenvironment, such as tumor immune infilt
Autor:
Hideki Kobara, Kayo Hirose, Shintaro Fujihara, Hisakazu Iwama, Tsutomu Masaki, Noriko Nishiyama
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4789, p 4789 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 9
International Journal of Molecular Sciences
Volume 22
Issue 9
Esophageal squamous cell carcinoma (ESCC) has a poor prognosis when diagnosed at an advanced stage, and early detection and treatment are essential to improve survival. However, intraobserver and interobserver variation make the diagnosis of superfic
Autor:
Hiromichi Kawaida, Nobuyuki Enomoto, Sumio Hirose, Yasuhiro Nakayama, Daisuke Ichikawa, Shinichi Takano, Taisuke Inoue, Natsuko Nakakuki, Tetsuo Kondo, Hitomi Takada, Makoto Kadokura, Satoshi Kawakami, Mitsuharu Fukasawa, Shinya Maekawa, Hiroshi Kono, Hiroshi Hayakawa, Ryoh Kato, Natsuhiko Kuratomi, Yoshimitsu Fukasawa, Hiroko Shindo, Ei Takahashi, Tatsuya Yamaguchi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3221, p 3221 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 6
International Journal of Molecular Sciences
Volume 22
Issue 6
New biomarkers are needed to further stratify the risk of malignancy in intraductal papillary mucinous neoplasm (IPMN). Although microRNAs (miRNAs) are expected to be stable biomarkers, they can vary owing to a lack of definite internal controls. To
Autor:
Bohyun Kim, Kwangsoo Kim, Cheol Lee, Jeong Hwan Park, Kyung Chul Moon, Minsun Jung, Young A Kim, Insoon Jang
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 628, p 628 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 2
International Journal of Molecular Sciences
Volume 22
Issue 2
A number of urinary bladder urothelial carcinoma (UB UC) mRNA-based classification systems have been reported. It also has been observed that treatment response and prognosis are different for each molecular subtype. In this study, cytokeratin (CK)5/
Autor:
Furdová A, Pooneh Chokhachi Baradaran, Bozena Smolkova, Lucia Demkova, Terezia Kurucova, Verona Buocikova, Andrea Soltysova, Dana Dvorská, Karin Jasek, Zuzana Dankova, Tatiana Sedlackova, Darina Lyskova, Gabriel Minarik, Pavel Babal, Viera Horvathova Kajabova
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 9651, p 9651 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Despite outstanding advances in diagnosis and the treatment of primary uveal melanoma (UM), nearly 50% of UM patients develop metastases via hematogenous dissemination, driven by the epithelial-mesenchymal transition (EMT). Despite the failure in UM
Autor:
Thorsten Schlomm, Jenny Roggisch, Anja Rabien, Ergin Kilic, Ralph M. Wirtz, Klaus Jung, Jan Gleichenhagen, Thomas Brüning, Minna Tervahartiala, Georg Johnen, Pekka Taimen, Adisch Kiani, Stefan Koch, Peter J. Boström, Thorsten H. Ecke, Frank Friedersdorff
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7420, p 7420 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 19
International Journal of Molecular Sciences
Volume 21
Issue 19
Objectives: Bladder cancer is a heterogeneous malignancy. Therefore, it is difficult to find single predictive markers. Moreover, most studies focus on either the immunohistochemical or molecular assessment of tumor tissues by next-generation sequenc
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7726, p 7726 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 20
International Journal of Molecular Sciences
Volume 21
Issue 20
Non-muscle-invasive bladder cancer (NMIBC) consists of transcriptional subtypes that are distinguishable from those of muscle-invasive cancer. We aimed to identify genetic signatures of NMIBC related to basal (K5/6) and luminal (K20) keratin expressi
Autor:
Karol Kajo, Peter Suran, Ivana Fridrichova, Lenka Kalinkova, Iveta Zmetakova, Miloslav Karhanek, Lenka Wachsmannova
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6071, p 6071 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 17
International Journal of Molecular Sciences
Volume 21
Issue 17
The discrimination of different subtypes of endometrial carcinoma (EC) is frequently problematic when using the current histomorphological classification
therefore, new markers for this differentiation are needed. Here, we examined differences i
therefore, new markers for this differentiation are needed. Here, we examined differences i
Autor:
Atsunari Kawashima, Eri Banno, Maria Del Carmen Rodriguez Pena, Eisuke Tomiyama, Hirotsugu Uemura, Taigo Kato, Diana Taheri, Kazutoshi Fujita, Motohide Uemura, Norio Nonomura, Koji Hatano, Hiroaki Fushimi, Kazuhiro Yoshimura, Takeshi Ujike, Seiji Yamaguchi, Tetsuya Takao, George J. Netto
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5390, p 5390 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 15
International Journal of Molecular Sciences
Volume 21
Issue 15
Enfortumab vedotin is a novel antibody&ndash
drug conjugate targeting Nectin-4, which is highly expressed in urothelial carcinoma. However, the expression status of Nectin-4 in upper tract urothelial carcinoma (UTUC) remains unclear. The relatio
drug conjugate targeting Nectin-4, which is highly expressed in urothelial carcinoma. However, the expression status of Nectin-4 in upper tract urothelial carcinoma (UTUC) remains unclear. The relatio